Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
- Conditions
- Interventions
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2022-10-13
- Target Recruit Count
- 274
- Registration Number
- NCT04184505
- Locations
- 🇮🇹
Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli" Po E. Morelli - Reggio Calabria - Uoc Ematologia, Reggio Calabria, Italy
🇮🇹Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia, Bologna, Italy
🇮🇹Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia - Università Degli Studi Di Torino, Torino, Italy
AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance
- Conditions
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2022-03-02
- Target Recruit Count
- 172
- Registration Number
- NCT04174612
- Locations
- 🇮🇹
Aou San Luigi Gonzaga - Orbassano - Scdu Ematologia Generale E Oncoematologia, Orbassano, Italy
🇮🇹Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy
🇮🇹Aou Policlinico P. Giaccone - Palermo - Uo Ematologia, Palermo, Italy
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 414
- Registration Number
- NCT04168502
- Locations
- 🇮🇹
ASL Le/1 P.O. Vito Fazzi - UO Ematologia, Lecce, Italy
🇮🇹Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy
🇮🇹Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy
The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide
- Conditions
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2024-10-22
- Target Recruit Count
- 5
- Registration Number
- NCT03804372
- Locations
- 🇮🇹
Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, (rm), Italy
🇮🇹Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia, Alessandria, Italy
🇮🇹Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
Long-term Outcomes for Acute Myeloid Leukemia Patients
- Conditions
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2020-03-04
- Target Recruit Count
- 343
- Registration Number
- NCT03755856
- Locations
- 🇧🇪
UZ Gasthuisberg, Leuven, Belgium
🇧🇪CHR Citadelle-CHU, Liège, Belgium
🇸🇮UKC Ljubljana, Ljubljana, Slovenia
Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 100
- Registration Number
- NCT03751917
- Locations
- 🇮🇹
U.O.C. Oncoematologia - Istituto Oncologico Veneto Irccs, Presidio Ospedaliero S. Giacomo Apostolo, Castelfranco Veneto, Italy
🇮🇹Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico UOC Oncoematologia, Milano, Italy
🇮🇹Azienda Ospedaliera "S.Gerardo", Monza, Italy
Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2022-03-16
- Target Recruit Count
- 7
- Registration Number
- NCT03668392
- Locations
- 🇮🇹
Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia, Roma, Italy
🇮🇹Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica, Ancona, Italy
🇮🇹Aso S. Croce E Carle - Cuneo - Sc Ematologia, Cuneo, Italy
Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-01-04
- Target Recruit Count
- 76
- Registration Number
- NCT03610438
- Locations
- 🇮🇹
I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy
🇮🇹Asst Grande Ospedale Metropolitano Niguarda - Milano - Sc Ematologia, Milano, Italy
🇮🇹Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia, Milano, Italy
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2022-05-12
- Target Recruit Count
- 104
- Registration Number
- NCT03545035
- Locations
- 🇮🇹
I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy
🇮🇹Aou Di Modena - Sc Ematologia, Modena, Italy
🇮🇹Aou Federico Ii - Napoli - Uoc Ematologia, Napoli, Italy
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
- First Posted Date
- 2018-05-18
- Last Posted Date
- 2022-05-12
- Target Recruit Count
- 109
- Registration Number
- NCT03528941
- Locations
- 🇮🇹
AOU Arcispedale S.Anna - UOC Ematologia e fisiopatologia della coagulazione, Cona, Ferrara, Italy
🇮🇹AOU Maggiore della Carità di Novara - SCDU Ematologia, Novara, Italy
🇮🇹AOU Città della Salute e della Scienza, Ospedale S.Giovanni Battista Molinette - SC Ematologia, Torino, Italy